FSUE Endopharm introduced a new medicine into civil circulation «Nefopam, film-coated tablets, 30 mg”. Marketing Authorization No. LP-008588.
The first batch of the medicine in the amount of more than 25,000 packages has already been shipped to distributors.
The medicine belongs to the “Other Analgesics and Antipyretics” pharmacotherapeutic group. Indications for use of the medicine “Nefopam, film-coated tablets, 30 mg”: acute and chronic pain, including postoperative, musculoskeletal and acute traumatic pain, as well as pain syndrome in oncological diseases.
Unlike narcotic drugs, nefopam hydrochloride does not cause respiratory failure.
The medicine is available on prescription.
Comment type is not specified in the component properties.